Human Study on IL-34 in Central Nervous System Disease
A systematic review identifies IL-34 as crucial for central nervous system (CNS) development and immune regulation, noting its dual role in neuroprotection and disease progression, particularly in neurological disorders like multiple sclerosis.
- Tags
- #MSResearch
- Most relevant to
- —
Why it matters
Understanding IL-34's functions may help unveil mechanisms underlying CNS disorders and could inform future research on potential therapeutic targets, though this review summarizes previously published literature rather than presenting new experimental data.
What this does not prove
This review does not provide original human study data or experimental evidence, as it synthesizes existing literature instead of reporting new findings.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Systematic review
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-09-04
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceIL-34 in neurological homeostasis and its multifaceted roles in central nervous system diseases. ↗DOI: 10.3389/fimmu.2026.1860233
Supporting passages (5)
study designThis review systematically outlines the core mechanisms by which the IL-34/CSF1R signaling axis regulates the development, colonization, and functional differentiation of CNS-resident immune cells-including microglia and border-associated macrophages (BAMs).
subjectsIt highlights its role in critical physiological processes such as synaptic pruning, neural circuit maturation, and maintenance of blood-brain barrier integrity.
findingsInterleukin-34 (IL-34), a ligand for the macrophage colony-stimulating factor receptor (CSF1R), plays an indispensable role in the development and homeostasis maintenance of the central nervous system (CNS).
publication datePublication date: 2026-09-04
limitationsTitle: IL-34 in neurological homeostasis and its multifaceted roles in central nervous system diseases.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.